Published in Antimicrob Agents Chemother on December 01, 2000
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 1.11
Antifungal activities and cytotoxicity studies of six new azasordarins. Antimicrob Agents Chemother (2001) 0.88
A chemical genomic screen in Saccharomyces cerevisiae reveals a role for diphthamidation of translation elongation factor 2 in inhibition of protein synthesis by sordarin. Antimicrob Agents Chemother (2008) 0.87
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding. Antimicrob Agents Chemother (2001) 0.86
Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 0.85
Improvement of sordarin production through process optimization: combining traditional approaches with DOE. J Ind Microbiol Biotechnol (2006) 0.85
Therapeutic efficacies of GW471552 and GW471558, two new azasordarin derivatives, against pneumocystosis in two immunosuppressed-rat models. Antimicrob Agents Chemother (2002) 0.79
Emerging drugs and vaccines for candidemia. Mycoses (2014) 0.77
Animal pharmacokinetics and interspecies scaling of sordarin derivatives following intravenous administration. Antimicrob Agents Chemother (2001) 0.77
Invasive aspergillosis. Clin Infect Dis (1998) 9.72
Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis (1991) 6.43
Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother (1988) 5.26
Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America. Clin Infect Dis (2000) 3.70
Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother (1996) 3.03
Epidemiology, diagnosis and treatment of systemic Candida infection in surgical patients under intensive care. Intensive Care Med (1998) 1.89
Identification of elongation factor 2 as the essential protein targeted by sordarins in Candida albicans. Antimicrob Agents Chemother (1998) 1.72
Sordarins: A new class of antifungals with selective inhibition of the protein synthesis elongation cycle in yeasts. Antimicrob Agents Chemother (1998) 1.63
Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother (1998) 1.43
Translation elongation factor 2 is part of the target for a new family of antifungals. Antimicrob Agents Chemother (1998) 1.30
Variation in fluconazole efficacy for Candida albicans strains sequentially isolated from oral cavities of patients with AIDS in an experimental murine candidiasis model. Antimicrob Agents Chemother (1996) 1.28
Activities of sordarins in murine histoplasmosis. Antimicrob Agents Chemother (1999) 1.21
Therapeutic drug monitoring of systemic antifungal therapy. J Antimicrob Chemother (1997) 1.12
Prevention of infection due to Pneumocystis carinii. Antimicrob Agents Chemother (1998) 1.11
In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats. Antimicrob Agents Chemother (2000) 0.97
Efficacies of sordarin derivatives GM193663, GM211676, and GM237354 in a murine model of systemic coccidioidomycosis. p6. Antimicrob Agents Chemother (2000) 0.96
Semisynthetic echinocandins affect cell wall deposition of Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother (1996) 0.95
Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol (1998) 0.92
Morphological evaluation of Pneumocystis carinii after extraction from infected lung. J Parasitol (1991) 0.87
Tail sectioning: a rapid and simple method for repeated blood sampling of the rat for corticosterone determination. Lab Anim Sci (1996) 0.86
Therapy of deep fungal infection in haematological malignancy. Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother (1997) 0.79
Long-term developmental outcome of infants with iron deficiency. N Engl J Med (1991) 5.51
Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med (1996) 4.44
Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics (2000) 3.79
Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics (1987) 2.74
Morphological variation and the process of domestication of Stenocereus stellatus (Cactaceae) in Central Mexico. Am J Bot (1999) 2.14
Pharmacokinetics of nevirapine in human immunodeficiency virus type 1-infected pregnant women and their neonates. Pediatric AIDS Clinical Trials Group Protocol 250 Team. J Infect Dis (1998) 2.08
Rate of Glycolate Formation During Photosynthesis at High pH. Plant Physiol (1966) 1.94
Traditional knowledge about mushrooms in a Nahua community in the state of Tlaxcala, Mexico. Mycologia (2010) 1.85
Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. Contraception (1990) 1.84
Transmission of Pneumocystis carinii disease from immunocompetent contacts of infected hosts to susceptible hosts. Eur J Clin Microbiol Infect Dis (2000) 1.55
Defects in mouse mammary gland development caused by conditional haploinsufficiency of Patched-1. Development (1999) 1.50
Postzoster cutaneous pseudolymphoma. Arch Dermatol (1994) 1.50
Iron-deficiency anemia and infant development: effects of extended oral iron therapy. J Pediatr (1996) 1.44
Sordarins: in vitro activities of new antifungal derivatives against pathogenic yeasts, Pneumocystis carinii, and filamentous fungi. Antimicrob Agents Chemother (1998) 1.43
The epidemiology of Entamoeba histolytica in Mexico City. A pilot survey I. Trans R Soc Trop Med Hyg (1980) 1.43
Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS (1998) 1.40
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Informant consensus factor and antibacterial activity of the medicinal plants used by the people of San Rafael Coxcatlán, Puebla, México. J Ethnopharmacol (2005) 1.31
Gender differences and regionalization of the cultural significance of wild mushrooms around La Malinche volcano, Tlaxcala, Mexico. Mycologia (2012) 1.30
The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol (2001) 1.21
Foreign body reaction to hemostatic materials mimicking recurrent brain tumor. Report of three cases. J Neurosurg (2001) 1.21
Attitudes regarding tuberculosis in immigrants from the Philippines to the United States. Fam Med (1999) 1.18
Pharmacokinetics-pharmacodynamics of a sordarin derivative (GM 237354) in a murine model of lethal candidiasis. Antimicrob Agents Chemother (2000) 1.17
Withdrawing and withholding life support in the intensive care unit: a Spanish prospective multi-centre observational study. Intensive Care Med (2001) 1.16
Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia. Histol Histopathol (2004) 1.11
Antifungal efficacy of GM237354, a sordarin derivative, in experimental oral candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 1.11
Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants. J Infect Dis (1999) 1.05
Usefulness of procalcitonin clearance as a prognostic biomarker in septic shock. A prospective pilot study. Med Intensiva (2012) 1.05
v-Src generates a p53-independent apoptotic signal. Mol Cell Biol (2000) 1.04
Improved adhesive method for microscopic examination of fungi in culture. J Clin Microbiol (1991) 1.03
Composition and antibacterial activity of essential oil of Lantana achyranthifolia Desf. (Verbenaceae). J Ethnopharmacol (2005) 1.02
Chronic effects of a high-fat diet enriched with virgin olive oil and a low-fat diet enriched with alpha-linolenic acid on postprandial endothelial function in healthy men. Br J Nutr (2008) 1.02
Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. J Infect Dis (2001) 1.01
Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines. AIDS Clinical Trial Group 230 Collaborators. J Infect Dis (2000) 1.01
No evidence of developmental III effects of low-level lead exposure in a developing country. J Dev Behav Pediatr (1994) 1.00
In vitro and in vivo antibacterial activities of E-4868, a new fluoroquinolone with a 7-azetidin ring substituent. Antimicrob Agents Chemother (1993) 1.00
Ethnobotany and antibacterial activity of some plants used in traditional medicine of Zapotitlán de las Salinas, Puebla (México). J Ethnopharmacol (2003) 1.00
High seroprevalence of Pneumocystis infection in Spanish children. Clin Microbiol Infect (2004) 0.99
Chronic administration of nevirapine during pregnancy: impact of pregnancy on pharmacokinetics. HIV Med (2008) 0.99
Disseminated mycoses in a dog by Paecilomyces sp. J Vet Med A Physiol Pathol Clin Med (2000) 0.98
Methods for accelerating the fluorescent-antibody test for rabies diagnosis. Appl Microbiol (1971) 0.97
In vitro pharmacodynamic parameters of sordarin derivatives in comparison with those of marketed compounds against Pneumocystis carinii isolated from rats. Antimicrob Agents Chemother (2000) 0.97
Magnetic resonance imaging in the evaluation of inflammatory lesions in muscular and soft tissues: an experimental infection model induced by Candida albicans. Magn Reson Imaging (1999) 0.95
Development of pneumocystosis animal models: corticosteroid-treated Wistar rat; SCID mouse and nude rat. J Eukaryot Microbiol (1998) 0.92
Antibacterial activity and pharmacokinetics of four new 7-azetidinyl fluoroquinolones. Antimicrob Agents Chemother (1996) 0.90
Genomic variability of Haemophilus influenzae isolated from Mexican children determined by using enterobacterial repetitive intergenic consensus sequences and PCR. J Clin Microbiol (2000) 0.90
Microplate assays for in vitro evaluation of anti-Pneumocystis drugs. J Eukaryot Microbiol (1998) 0.89
Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation (1992) 0.89
Antifungal activities and cytotoxicity studies of six new azasordarins. Antimicrob Agents Chemother (2001) 0.88
Association between polymorphisms of folate-metabolizing enzymes and risk of prostate cancer. Eur J Surg Oncol (2007) 0.87
Serum levels of intercellular adhesion molecule 1 (ICAM-1) in patients with colorectal cancer: inhibitory effect on cytotoxicity. Eur J Cancer (1998) 0.87
Evaluation of risk of deterministic effects in fluoroscopically guided procedures. Radiat Prot Dosimetry (2006) 0.86
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein binding. Antimicrob Agents Chemother (2001) 0.86
Human immunodeficiency virus-related lymphoreticular malignancies and peripheral neurologic disease. A report of four cases. Cancer (1988) 0.86
Osteolysis associated with cemented total knee arthroplasty. J Arthroplasty (1998) 0.86
Endothelium-dependent relaxation to acetylcholine in bovine oviductal arteries: mediation by nitric oxide and changes in apamin-sensitive K+ conductance. Br J Pharmacol (1995) 0.85
Antifungal activities of two new azasordarins, GW471552 and GW471558, in experimental models of oral and vulvovaginal candidiasis in immunosuppressed rats. Antimicrob Agents Chemother (2001) 0.85
Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens (2001) 0.84
Serum prolactin levels and behavior in infants. Biol Psychiatry (1995) 0.84
[Aspergillosis: Mechanisms of pathogenicity implicated and approach to laboratory diagnosis.]. Rev Iberoam Micol (1998) 0.83
Vertical human immunodeficiency virus transmission: a study of placental pathology in relation to maternal risk factors. Am J Perinatol (1994) 0.82
Cross-reactivity between Candida albicans and human ovarian carcinoma as revealed by monoclonal antibodies PA10F and C6. Br J Cancer (1998) 0.82
Nitric oxide and salt sensitivity. Am J Hypertens (2000) 0.82
Differential mechanisms of urethral smooth muscle relaxation by several NO donors and nitric oxide. Naunyn Schmiedebergs Arch Pharmacol (1999) 0.82
Successful airway control with the laryngeal mask in an infant with Beckwith-Wiedemann syndrome and hepatoblastoma for central line catheterization. Paediatr Anaesth (2000) 0.82
Aneurysmal bone cyst of the temporal bone. Pediatr Neurosurg (1999) 0.82
E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens. Antimicrob Agents Chemother (1995) 0.82
Recovery of visual function in anterior ischemic optic neuropathy due to giant cell arteritis. Am J Med (1992) 0.82
Basal plasma concentrations of plant sterols can predict LDL-C response to sitosterol in patients with familial hypercholesterolemia. Eur J Clin Nutr (2007) 0.81
Protective mechanisms of adenosine 5'-monophosphate in platelet activation and thrombus formation. Thromb Haemost (2013) 0.81
c-myc, c-erb-B2, nm23 and p53 expression in human endometriosis. Oncol Rep (1998) 0.81
Co-expression of the MDR1 gene and HSP27 in human ovarian cancer. Anticancer Res (1998) 0.81
Correlation of MDR1 expression and oncogenic activation in human epithelial ovarian carcinoma. Anticancer Res (1997) 0.80
Fetal organs infected by HIV-1. AIDS (1993) 0.80
Polymorphism at the TRIB1 gene modulates plasma lipid levels: insight from the Spanish familial hypercholesterolemia cohort study. Nutr Metab Cardiovasc Dis (2010) 0.80
Characterization of postsynaptic alpha-adrenoceptors in the arteries supplying the oviduct. Br J Pharmacol (1992) 0.80
Analytical performance characteristics of the Abbott Architect i2000 Tacrolimus assay; comparisons with liquid chromatography-tandem mass spectrometry (LC-MS/MS) and Abbott IMx methods. Clin Chim Acta (2009) 0.79
Effect of thyroid hormones on angiotensinogen production in the rat in vivo and in vitro. J Endocrinol (1987) 0.79
N-acetylcysteine downregulates vascular endothelial growth factor production by human keratinocytes in vitro. Arch Dermatol Res (2000) 0.79
Comparison of COS cell transfected AT1A and AT1B angiotensin II receptors and angiotensin II receptor isoforms in rat tissues using isoelectric focusing. Biochem Biophys Res Commun (1993) 0.79
Policy instruments for pollution control in developing countries. World Bank Res Obs (1992) 0.78
[Rett's syndrome in the Spanish population]. Rev Neurol (1999) 0.78
Age-related differences in cardiac susceptibility to ischemia/reperfusion injury. Response to deferoxamine. J Thorac Cardiovasc Surg (1992) 0.78
Deferoxamine fails to improve postischemic cardiac function in hypertrophied hearts. Circulation (1990) 0.78
Biphasic response of complement to heparin: fluid-phase generation of neoantigens in human serum and in a reconstituted alternative pathway amplification cycle. Am J Hematol (1995) 0.78
Distortion product otoacoustic emissions in healthy newborns: normative data. Acta Otolaryngol (1995) 0.77
Differential blood pressure effects of oral glucose and intravenous L-arginine in healthy lean normotensive and obese hypertensive subjects. J Hum Hypertens (2002) 0.77
Angioimmunoblastic lymphadenopathy and transient Fanconi syndrome. Nephron (1985) 0.77